• Department of Radiotherapy, The EENT Hospital of Fudan University, Shanghai 200031 China;
WangShengzi, Email: shengziwang@fudan.edu.cn
Export PDF Favorites Scan Get Citation

Objective To observe the effectiveness of radiotherapy for refractory choroidal hemangioma. Methods Eight patients (8 eyes) with choroidal hemangioma were enrolled in this retrospective study. All the patients had received laser or photodynamic therapy before without effectiveness. The patients included 7 males and 1 females. The age was ranged from 11 to 54 years old, with an average of (27.50±15.18) years. All the patients were affected unilaterally, including 3 right eyes and 5 left eyes. There were 5 eyes with circumscribed choroidal hemangioma, 3 eyes with diffused choroidal hemangioma. All eyes had extensively exudative retinal detachment. The vision was from light sensation to 0.01. The volume of the tumors was ranged from 1.96 to 5.35 cm3, with a mean of (3.37±1.06) cm3. All the patients were treated with X rays by conventional fractional radiotherapy. Four of 8 patients were applied 24Gy totally in 8 fractions, while the other 4 patients were applied 46Gy in 23 fractions. Follow-up period ranged from 7 to 95 months, with medium of 42 months. Results Retinas reattached in all the eyes while exudation being absorbed. No retinal detachment happened again. To the last follow-up, the vision was from light sensation to 0.6. Visual activity improved in 6 eyes while 2 eyes improved obviously. Visual acuity was stable in remaining 2 eyes. The volume of the tumors decreased to 1.24-2.16 cm3, with a mean of (1.68±0.30) cm3. The percentage of the tumor decreased by 14.6-72.7, with an average of (44.89±21.30)%. No radiotherapy-associated complication occurred. Conclusion Radiotherapy is an efficient and safe treatment for refractory choroidal hemangioma.

Citation: LiJi, WangShengzi, XuGezhi. Radiotherapy for refractory choroidal hemangioma. Chinese Journal of Ocular Fundus Diseases, 2014, 30(5): 470-472. doi: 10.3760/cma.j.issn.1005-1015.2014.05.010 Copy

  • Previous Article

    Intravitreal injection of ranibizumab for retinal angiomatous proliferation
  • Next Article

    Ocular ischemic appearance associated with carotid artery stenosis and its influence factor